Related Experiment Video
Updated: May 15, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Intragenic viral silencer element regulates HTLV-1 latency via RUNX complex recruitment
Kenji Sugata1, Akhinur Rahman1, Koki Niimura1,2
1Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Human T cell leukaemia virus type 1 (HTLV-1) uses a silencer region to achieve latency, unlike HIV-1. This mechanism, involving RUNX1 binding, aids HTLV-1 persistence and may offer therapeutic targets.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Retroviruses like HTLV-1 and HIV-1 integrate into host genomes for persistent infections.
- HTLV-1 establishes latency and can cause leukaemia, while HIV-1 causes immune collapse.
- Mechanisms for HTLV-1's latency preference are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms behind HTLV-1's latency.
- To identify host-viral interactions regulating HTLV-1 gene expression.
- To explore potential therapeutic strategies for HTLV-1 infection.
Main Methods:
- Analysis of blood samples from individuals with HTLV-1 infection.
- Identification and characterization of an open chromatin region within the HTLV-1 provirus.
- Investigating the role of host transcription factor RUNX1 binding.
Main Results:
- An open chromatin region within the HTLV-1 provirus acts as a transcriptional silencer, regulating viral expression.
- The host transcription factor RUNX1 binds to this silencer, repressing HTLV-1 replication.
- Mutating the silencer increases HTLV-1 replication and immunogenicity; its insertion into HIV-1 reduces viral production.
Conclusions:
- HTLV-1 employs a transcriptional silencer regulated by RUNX1 for long-term persistence.
- This mechanism highlights a key difference in infection strategies between HTLV-1 and HIV-1.
- The identified silencer represents a potential target for novel antiviral therapies.
More Related Videos
07:18High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
Non-LTR Retrotransposons
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Inheritance of Chromatin Structures